Dr. Iacono

Aldo T. Iacono, M.D. Aldo T. Iacono, M.D.
Professor of Medicine
Medical Director, Lung Transplant Program

Department: Division
Medicine: Pulmonary and Critical Care Medicine

Special Interests: Aerosolized cyclosporine as anti-rejection medication; preventing complications of lung transplantation
Medical Degree: University of Bologna
Residency: Brooklyn Hospital; SUNY Downstate
Fellowship: SUNY Stony Brook
Certification: Internal Medicine; Pulmonary Diseases; Critical Care Medicine


Dr. Iacono joined the University of Maryland faculty from University of Pittsburgh School of Medicine where he served as Medical Director of Lung Transplantation. Dr. Iacono has established a national reputation as an outstanding transplant pulmonologist and a translational investigator focusing on novel anti-rejection therapy. He has been a leader in developing aerosolized antirejection therapy to reduce the incidence of chronic lung transplant rejection and minimize systemic side effects of antirejection medications.

Current Research Interests:

  • Complications of lung transplantiation
  • Markers of lung transplant rejection
  • Novel anti-rejection therapies
  • Aerosolized anti-rejection therapy for lung transplant patients

Current Research Funding:

  • NIH R01 HL59490, “Aerosol Cyclosporine As Prevention of Allograft Rejection” (PI: Iacono) Years: 1997-2001. Direct cost: 1,706,795, Total Budget: 2,376,085
  • Chiron, “Commercialization of Aerosol Cyclosporine” (PI: Iacono); Years: 2004-present. Total Budget: $110,000


  • MD University of Bologna (1985)
  • House Staff Training; Brooklyn Hospital, SUNY Downstate (1989)
  • Fellowship training: SUNY Stony Brook (1992)

Contact Information:
1-800-373-4111 (physicians only)
1-800-492-5538 (patients only)
1-410-328-8919 (news media only)

Average rating:
(based on 0 ratings)